216 related articles for article (PubMed ID: 24211713)
1. TSPAN33 is a novel marker of activated and malignant B cells.
Luu VP; Hevezi P; Vences-Catalan F; Maravillas-Montero JL; White CA; Casali P; Llorente L; Jakez-Ocampo J; Lima G; Vilches-Cisneros N; Flores-Gutiérrez JP; Santos-Argumedo L; Zlotnik A
Clin Immunol; 2013 Dec; 149(3):388-99. PubMed ID: 24211713
[TBL] [Abstract][Full Text] [Related]
2. Tspan33 is Expressed in Transitional and Memory B Cells, but is not Responsible for High ADAM10 Expression.
Pérez-Martínez CA; Maravillas-Montero JL; Meza-Herrera I; Vences-Catalán F; Zlotnik A; Santos-Argumedo L
Scand J Immunol; 2017 Jul; 86(1):23-30. PubMed ID: 28449222
[TBL] [Abstract][Full Text] [Related]
3. Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling.
Rizzello C; Cancila V; Sangaletti S; Botti L; Ratti C; Milani M; Dugo M; Bertoni F; Tripodo C; Chiodoni C; Colombo MP
Mol Cancer; 2022 Dec; 21(1):215. PubMed ID: 36503430
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S
Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
[TBL] [Abstract][Full Text] [Related]
5. The Tetraspanin TSPAN33 Controls TLR-Triggered Macrophage Activation through Modulation of NOTCH Signaling.
Ruiz-García A; López-López S; García-Ramírez JJ; Baladrón V; Ruiz-Hidalgo MJ; López-Sanz L; Ballesteros Á; Laborda J; Monsalve EM; Díaz-Guerra MJ
J Immunol; 2016 Oct; 197(8):3371-3381. PubMed ID: 27574297
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous B cell hyperactivity in autoimmune-prone MRL mice.
Nijnik A; Ferry H; Lewis G; Rapsomaniki E; Leung JC; Daser A; Lambe T; Goodnow CC; Cornall RJ
Int Immunol; 2006 Jul; 18(7):1127-37. PubMed ID: 16735376
[TBL] [Abstract][Full Text] [Related]
7. Tetraspanin 33 (TSPAN33) regulates endocytosis and migration of human B lymphocytes by affecting the tension of the plasma membrane.
Navarro-Hernandez IC; López-Ortega O; Acevedo-Ochoa E; Cervantes-Díaz R; Romero-Ramírez S; Sosa-Hernández VA; Meza-Sánchez DE; Juárez-Vega G; Pérez-Martínez CA; Chávez-Munguía B; Galván-Hernández A; Antillón A; Ortega-Blake I; Santos-Argumedo L; Hernández-Hernández JM; Maravillas-Montero JL
FEBS J; 2020 Aug; 287(16):3449-3471. PubMed ID: 31958362
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of B lymphocyte-induced maturation protein-1 reduces the production of autoantibody and alleviates symptoms of systemic lupus erythematosus.
Luo J; Niu X; Zhang M; Zhang K; Chen M; Deng S
Autoimmunity; 2015 Mar; 48(2):80-6. PubMed ID: 25347333
[TBL] [Abstract][Full Text] [Related]
9. DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo.
Lenert P; Yasuda K; Busconi L; Nelson P; Fleenor C; Ratnabalasuriar RS; Nagy PL; Ashman RF; Rifkin IR; Marshak-Rothstein A
Arthritis Res Ther; 2009; 11(3):R79. PubMed ID: 19476613
[TBL] [Abstract][Full Text] [Related]
10. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.
Xu M; Hou R; Sato-Hayashizaki A; Man R; Zhu C; Wakabayashi C; Hirose S; Adachi T; Tsubata T
J Immunol; 2013 Jun; 190(11):5436-45. PubMed ID: 23616572
[TBL] [Abstract][Full Text] [Related]
11. Siglec-G deficiency leads to more severe collagen-induced arthritis and earlier onset of lupus-like symptoms in MRL/lpr mice.
Bökers S; Urbat A; Daniel C; Amann K; Smith KG; Espéli M; Nitschke L
J Immunol; 2014 Apr; 192(7):2994-3002. PubMed ID: 24600033
[TBL] [Abstract][Full Text] [Related]
12. Expression of APRIL in diffuse large B cell lymphomas from patients with systemic lupus erythematosus and rheumatoid arthritis.
Löfström B; Backlin C; Pettersson T; Lundberg IE; Baecklund E
J Rheumatol; 2011 Sep; 38(9):1891-7. PubMed ID: 21724695
[TBL] [Abstract][Full Text] [Related]
13. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
[TBL] [Abstract][Full Text] [Related]
14. Altered Expression of TSPAN32 during B Cell Activation and Systemic Lupus Erythematosus.
Fagone P; Mangano K; Di Marco R; Reyes-Castillo Z; Muñoz-Valle JF; Nicoletti F
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34207245
[TBL] [Abstract][Full Text] [Related]
15. AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4.
White CA; Seth Hawkins J; Pone EJ; Yu ES; Al-Qahtani A; Mai T; Zan H; Casali P
Autoimmunity; 2011 Dec; 44(8):585-98. PubMed ID: 21585311
[TBL] [Abstract][Full Text] [Related]
16. Malignant lymphoma in patients with systemic rheumatic disease (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, and dermatomyositis): a clinicopathologic study of 24 Japanese cases.
Kojima M; Itoh H; Shimizu K; Saruki N; Murayama K; Higuchi K; Tamaki Y; Matsumoto M; Hirabayashi K; Igarishi S; Masawa N; Nakamura S
Int J Surg Pathol; 2006 Jan; 14(1):43-8. PubMed ID: 16501834
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of FcγRIIB regulates downstream protein phosphorylation and suppresses B cell activation to ameliorate systemic lupus erythematosus.
Sheng L; Cao X; Chi S; Wu J; Xing H; Liu H; Yang Z
Int J Mol Med; 2020 Oct; 46(4):1409-1422. PubMed ID: 32945349
[TBL] [Abstract][Full Text] [Related]
18. Oridonin ameliorates lupus-like symptoms of MRL(lpr/lpr) mice by inhibition of B-cell activating factor (BAFF).
Zhou L; Sun L; Wu H; Zhang L; Chen M; Liu J; Zhong R
Eur J Pharmacol; 2013 Sep; 715(1-3):230-7. PubMed ID: 23712004
[TBL] [Abstract][Full Text] [Related]
19. Impaired B cell inhibition by lupus bone marrow mesenchymal stem cells is caused by reduced CCL2 expression.
Che N; Li X; Zhang L; Liu R; Chen H; Gao X; Shi S; Chen W; Sun L
J Immunol; 2014 Nov; 193(10):5306-14. PubMed ID: 25339674
[TBL] [Abstract][Full Text] [Related]
20. A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study.
Löfström B; Backlin C; Sundström C; Ekbom A; Lundberg IE
Ann Rheum Dis; 2007 Dec; 66(12):1627-32. PubMed ID: 17517757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
